Physician profile
Daniel G Fuller
NPI 1023087632
$8,362.33
in general payments reported to CMS, 2019-2025
13 companies · $464 in 2025
The $464 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2021: $3,123 · 2022: $2,192 · 2023: $1,831 · 2024: $411 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,455 · Food and Beverage: $1,101 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,455.00 |
| Food and Beverage | $1,101.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,395.37 | 2021-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Kxl1b-Ce-Marked Kxlsystem |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,845.44 | 2019-2021 | |
| Coopervision INC. | $1,251.41 | 2019-2025 | Clariti Contact Lens, Rose K Contact Lens |
| Johnson & Johnson Vision Care, INC. | $304.93 | 2019-2024 | Acuvue |
| Alcon Vision LLC | $224.47 | 2022-2024 | Air Optix, Total30 |
| Allergan, INC. | $113.85 | 2019 | |
| Biotissue Holdings INC. | $77.65 | 2022 | |
| Bausch & Lomb Americas INC. | $35.54 | 2022-2023 | Infuse |
| Abbvie INC. | $33.48 | 2025 | |
| Mallinckrodt Hospital Products INC. | $33.22 | 2025 | Acthar |
| Dompe US, INC. | $18.17 | 2024 | Oxervate |
| Sight Sciences, INC. | $14.74 | 2023 | Tearcare System |
| Carl Zeiss Meditec, INC. | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.